Literature DB >> 30447683

Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis.

Lanqi Guo1, Jianfeng Xie1, Yingzi Huang1, Chun Pan1, Yi Yang1, Haibo Qiu1, Ling Liu2.   

Abstract

BACKGROUND: Mortality in patients with acute respiratory distress syndrome (ARDS) remains high. These patients require mechanical ventilation strategies that include high positive end-expiratory pressure (PEEP). It remains controversial whether high PEEP can improve outcomes for ARDS patients, especially patients who show improvement in oxygenation in response to PEEP. In this meta-analysis, we aimed to evaluate the effects of high PEEP on ARDS patients.
METHODS: We electronically searched randomized controlled trials (RCTs) reported in the MEDLINE, CENTRAL, EMBASE, CINAHL and Web of Science databases from January 1990 to December 2017. Meta-analyses of the effects of PEEP on survival in adults with ARDS were conducted using the methods recommended by the Cochrane Collaboration.
RESULTS: A total of 3612 patients from nine randomized controlled trials (RCTs) were included. There were 1794 and 1818 patients in the high and low PEEP groups, respectively. Hospital mortality showed no significant difference between the high and low PEEP groups (RR = 0.92; 95% CI, 0.79 to 1.07; P = 0.26). Similar results were found for 28-d mortality (RR = 0.88; 95% CI, 0.72 to 1.07; P = 0.19) and ICU mortality (RR = 0.83; 95% CI, 0.65 to 1.07; P = 0.15). The risk of clinically objectified barotrauma was not significantly different between the high and low PEEP groups (RR = 1.24; 95% CI, 0.74 to 2.09, P = 0.41). In the subgroup of ARDS patients who responded to increased PEEP by improved oxygenation (from 6 RCTs), high PEEP significantly reduced hospital mortality (RR = 0.83; 95% CI 0.69 to 0.98; P = 0.03), ICU mortality (RR = 0.74; 95% CI, 0.56 to 0.98; P = 0.04),but the 28-d mortality was not decreased(RR = 0.83; 95% CI, 0.67 to 1.01; P = 0.07). For ARDS patients in the low PEEP group who received a PEEP level lower than 10 cmH2O (from 6 RCTs), ICU mortality was lower in the high PEEP group than the low PEEP group (RR = 0.65; 95% CI, 0.45 to 0.94; P = 0.02).
CONCLUSIONS: For ARDS patients who responded to increased PEEP by improved oxygenation, high PEEP could reduce hospital mortality, ICU mortality and 28-d mortality. High PEEP does not increase the risk of clinically objectified barotrauma.

Entities:  

Keywords:  ARDS; Barotrauma; Meta; Mortality; PEEP

Mesh:

Year:  2018        PMID: 30447683      PMCID: PMC6240288          DOI: 10.1186/s12871-018-0631-4

Source DB:  PubMed          Journal:  BMC Anesthesiol        ISSN: 1471-2253            Impact factor:   2.217


Background

Acute respiratory distress syndrome (ARDS) is a common clinical syndrome that has significant morbidity and mortality [1]. In patients with acute respiratory distress syndrome, mechanical ventilation with a lower tidal volume could decrease mortality [2]. Numerous approaches had been adopted to improve lung-protective ventilation strategies, but the mortality of ARDS remains high. Three large RCTs were performed to assess if higher PEEP could improve outcomes in patients with ARDS [3-5]. All of the trials failed to find that higher PEEP could improve the survival of ARDS patients. However, higher PEEP showed benefits in severe ARDS patients in subgroup analysis. High PEEP can improve the PaO2/FiO2 compared with low PEEP. PEEP is an easily implemented intervention that is primarily used to prevent atelectasis and to correct hypoxemia caused by alveolar hypoventilation. Borges et al. showed that recruitment manoeuvres with PEEP and subsequent maintenance of a high level of PEEP reversed the collapse of alveoli and improved oxygenation [6]. Putensen’s study showed better outcomes with routine use of low tidal volume but not high PEEP ventilation in unselected patients with ARDS [7]. Recently, the Alveolar Recruitment for ARDS Trial found that in patients with moderate to severe ARDS, a strategy of lung recruitment and titrated PEEP compared with low PEEP decreased 28-day all-cause mortality [8]. A meta-analysis showed that higher PEEP could improve survival in ARDS patients with a PaO2/FiO2 less than 200 mmHg [9]. These findings indicated that higher PEEP needed to be used in patients who potentially benefit from it. PEEP is a double-edged sword when it is used in ARDS patients. PEEP could open the collapsed alveoli in the dependent lung and may induce hyperinflation in the nondependent lung. Therefore, higher PEEP could improve outcomes based on lung recruitablity in ARDS patients [2]. According to the findings from Goligher’s study [10], patients who responded to increased PEEP by improved oxygenation, defined as positive oxygenation response to PEEP, might benefit more from higher PEEP. Thus, we speculated that PEEP could have different effects on clinical outcomes according to the nature of the clinical response to PEEP itself. Therefore, we conducted this meta-analysis to establish whether higher PEEP could improve survival among specific subgroups of ARDS patients who show improvement in oxygenation as a response to increased PEEP.

Methods

Eligibility criteria and information sources

We electronically searched randomized controlled trials (RCTs) published in the MEDLINE, EMBASE, CINAHL and Web of Science databases from January 1990 to December 2017. Additional files 1, 2, 3, 4, 5, 6, 7, 8, and 9 and supplementary appendices of the relevant articles were also reviewed.

Search and study selection

To avoid bias, two investigators assessed the appropriateness of retrieved studies by considering the titles, abstracts and citations independently. The following keywords were used: “ALI” or “acute lung injury”, or “ARDS”, or “acute respiratory distress syndrome”, or “ARF”, or “acute respiratory failure”, and “PEEP”, or “positive end-expiratory pressure”, mortality, ICU mortality and barotrauma. The reviewers evaluated the studies based on the inclusion and exclusion criteria, and they worked out any differences by consensus. The study subjects were limited to “human”. Because a meta-analysis has as its research material previously published data, this research required no ethical approval or patient consent. We only included randomized controlled clinical trials that compared high PEEP with low PEEP in acute respiratory failure, acute lung injury or acute respiratory distress syndrome, whether to ventilate with low tidal volume, that provided the numbers of patients with high PEEP and low PEEP, and that reported patient mortality. We excluded retrospective studies and studies in which previously published data were re-analysed. We also excluded studies involving children and infants.

Data items

Clinically objectified barotrauma was defined as the presence of pneumothorax on chest radiograph or chest tube insertion for any new pneumothorax, pneumomediastinum, subcutaneous emphysema, or pneumatocele after random assignment. The hospital mortality, ICU mortality and 28-day mortality and the incidence of clinically objectified barotrauma were extracted.

Quality assessment

Two reviewers independently assessed the quality of RCTs, extracted data, and cross-checked the results. Any disagreements were resolved by a third party. The quality evaluation criteria were assessed by the 5-point scale Jadad scale [5]. The total score was 1–5 (1–2: low-quality research; 3–5: high-quality research). This instrument grades (a) the use of randomization, (b) the use of blinding, (c) the handling of withdrawals and dropouts, (d) the comparability of baselines between groups, and (e) the similarity to other treatment interventions and the accuracy of intervention. The other method to assess the quality of RCTs was assessing the randomization method according to the criteria from the Cochrane Collaboration (Fig. 1).
Fig. 1

Cochrane risk of bias assessment for mortality outcome

Cochrane risk of bias assessment for mortality outcome

Sub-group analysis

According to Goligher’s study [10], we defined positive oxygenation response to PEEP as ΔPaO2/FiO2 > 0 mmHg when compared mean PaO2/FiO2 at baseline (lower PEEP) and after PEEP increased to a higher PEEP level in the high PEEP group. However, in the low PEEP group, oxygenation response to PEEP was unavailable because the baseline PEEP did not increase to a high level during the study period. We analysed the sub-groups according to whether patients in the high PEEP group had positive oxygenation response to PEEP to determine whether high PEEP could improve outcomes in patients who respond to increased PEEP by improved oxygenation. In addition, the PEEP value in the low PEEP group and the severity of ARDS also affected whether high PEEP reduced mortality. Therefore, we also performed sub-group analysis to determine whether PEEP greater than 10 cmH2O in the low PEEP group or baseline PaO2/FiO2 equal to or less than 150 mmHg could have some effect on mortality between the high and low PEEP groups.

Summary measures

The meta-analysis was performed according to the Cochrane Collaboration guidelines. All statistical analyses were performed with Review Manager, version 5.3 (the Nordic Cochrane Centre, Copenhagen, Denmark), the Cochrane Collaboration’s software for preparing and maintaining Cochrane systematic reviews. The pooled-effects estimates for binary variables are expressed as risk ratios with 95% CIs, whereas continuous variables are expressed as weighted mean differences with 95% CIs.

Synthesis of results

We tested the difference in the estimated value of the treatment effect between the experimental and control groups with a 2-sided z-test. Statistical significance was defined as P < 0.05. We predefined heterogeneity as low, moderate, and high with I statistics greater than 25, 50, and 75%, respectively [11]. A meta-analysis with a random-effects model was applied with I statistics greater than 50%. For other I values, a fixed-effects model was selected. Funnel plot were used to analyse publication bias.

Results

Study selection

Our initial electronic and manual search identified 8124 studies. Ultimately, nine RCTs fulfilled the inclusion criteria and were included in the cumulative meta-analysis (Fig. 2). The characteristics of the included studies are shown in Table 1. A total of 3612 patients, including 1794 patients in the high PEEP group and 1818 patients in the low PEEP group, were included in our meta-analysis.
Fig. 2

Study flow diagram

Table 1

Characteristics of the included patients

TrialJadad scoreInclusion criteriamethod of PEEP selectionNumber of Patients(HP/LP)Age(HP/LP)PEEP(cmH2O)(HP/LP)Gender(HP vs. LP)[male/female]PaO2/FIO2(mmHg)(HP/LP)
Amato/1998 [12]3Lung injury score ≥ 2.5HPa:LIPc + 2 cmH2OLPb:FiO2-PEEP29/ 2436/3313.2 ± 0.4/9.3 ± 0.5112/134
Ranieri/1999 [13]3PaO2:FIO2 ≤ 200 mmHgHPa:LIPc + 2 cm H2OLPb:FiO2-PEEP18/1951/4914.8 ± 2.7/6.5 ± 1.77/11 vs. 10/19149/142
Brower/2004 [3]4PaO2:FIO2 ≤ 300 mmHgHPa:FiO2-PEEP (ARDSnet)LPb:FiO2-PEEP (PEEP more than 12 cmH2O)276/27354/4914.7 ± 3.5/8.9 ± 3.5145/128 vs.157/119151/165
Villar/2006 [14]3PaO2:FIO2 ≤ 200 mmHgHPa:LIPc + 2 cmH2OLPb:FiO2-PEEP50/4548/5214.1 ± 2.8/9.0 ± 2.723/27 vs.27/18111/109
Meade/2008 [5]4PaO2:FIO2 ≤ 250 mmHgFiO2-PEEP475/50854.5/56.915.6 ± 3.9/10.1 ± 3.0282/193 vs. 307/201144.8/144.6
Mercat/2008 [15]4PaO2:FIO2 ≤ 300 mmHgHPa:PplatLPb: FiO2-PEEP385/38260/6014.6 ± 3.2/7.1 ± 1.8260/125 vs. 256/126144/143
Talmor/2008 [16]3PaO2:FIO2 ≤ 200 mmHgHPa:Transpulmonary pressureLPb:FiO2-PEEP30/3154.5/51.217 ± 6.0/10 ± 4.019/11 vs. 17/1491/107
Huh/2009 [17]3PaO2:FIO2 ≤ 200 mmHgHPa:saturation decrease more than 2% and drop of static complianceLPb:FiO2-PEEP30/2755/6218/12 vs. 17/10115/110
ART/2017 [8]3PaO2:FIO2 ≤ 200 mmHgHPa: Maximum alveolar recruitment by compliance + 2 cmH2OLPb: FiO2-PEEP501/50951.3/5616.8 ± 3.8/13.0 ± 0.3313/188 vs. 318/191119.5/117.2

aHP High PEEP group, bLP Low PEEP group, cLIP lower inflection point

Study flow diagram Characteristics of the included patients aHP High PEEP group, bLP Low PEEP group, cLIP lower inflection point

Effect of high PEEP on hospital mortality in ARDS patients

There was no difference in hospital mortality between the high PEEP and low PEEP groups (RR = 0.92; 95% CI, 0.79 to 1.07; P = 0.26) (Fig. 3). In ARDS with positive oxygenation response to PEEP (from 4 RCTs), hospital mortality was lower in the high PEEP group than the low PEEP group (RR = 0.83; 95% CI, 0.69 to 0.98; P = 0.03) (Fig. 3). However, hospital mortality was comparable between groups in patients without positive oxygenation response to PEEP (RR = 1.08; 95% CI, 0.98 to 1.18; P = 0.1) (Fig. 3).
Fig. 3

Effect of high PEEP on hospital mortality in ARDS patients with or without positive oxygenation response to PEEP

Effect of high PEEP on hospital mortality in ARDS patients with or without positive oxygenation response to PEEP For ARDS patients in the low PEEP group who received a PEEP level lower than 10 cmH2O (from 4 RCTs), hospital mortality was no different in the high and low PEEP groups (RR = 0.83; 95% CI, 0.64 to 1.08; P = 0.16) (Fig. 4). There was no significant difference in hospital mortality between high and low PEEP groups (RR = 1.0; 95% CI, 0.84 to 1.19; P = 0.97) for ARDS patients in the low PEEP group who received a PEEP level equal or higher than 10 cmH2O (Fig. 4). For ARDS patients with baseline PaO2/FiO2 ≤ 150 mmHg (from 5 RCTs), there was no significant difference in hospital mortality between high and low PEEP groups (RR = 0.88; 95% CI, 0.74 to 1.05; P = 0.15) (Fig. 5).
Fig. 4

Effect of high PEEP on hospital mortality while the PEEP level of patients in low PEEP group was different

Fig. 5

Effect of high PEEP on hospital mortality of moderate and severe ARDS patients between high and low PEEP groups

Effect of high PEEP on hospital mortality while the PEEP level of patients in low PEEP group was different Effect of high PEEP on hospital mortality of moderate and severe ARDS patients between high and low PEEP groups

Effect of high PEEP on 28-day mortality in ARDS patients

Twenty-eight-day mortality was reported in seven RCTs and was similar in the high and low PEEP groups (RR = 0.88; 95% CI,0.72 to 1.07; P = 0.19) (Fig. 6). In ARDS patients with positive oxygenation response to PEEP (5 RCTs), 28-day mortality was lower in the high PEEP group than the low PEEP group (RR = 0.83; 95% CI, 0.67 to 1.01; P = 0.07) (Fig. 6).
Fig. 6

Effect of high PEEP on 28-day mortality in ARDS patients

Effect of high PEEP on 28-day mortality in ARDS patients There was no difference in 28-day mortality between the high and low PEEP groups, regardless of the PEEP level used in the low PEEP group (For PEEP less than 10 cmH2O, RR = 0.80; 95% CI, 0.60 to 1.07; P = 0.14) (For PEEP equal and more than10 cmH2O, RR = 0.93; 95% CI, 0.70 to 1.24; P = 0.64) (Fig. 7).
Fig. 7

Effect of high PEEP on 28-day mortality while the PEEP level of patients in low PEEP group was different

Effect of high PEEP on 28-day mortality while the PEEP level of patients in low PEEP group was different

Effect of high PEEP on ICU mortality in ARDS patients

ICU mortality was reported in five RCTs. A high PEEP strategy did not decrease the ICU mortality compared to the low PEEP strategy (RR = 0.83; 95% CI, 0.65 to 1.07; P = 0.15) (Fig. 8). In ARDS with positive oxygenation response to PEEP (4 RCTs), ICU mortality was lower in the high PEEP group than the low PEEP group (RR = 0.74; 95% CI, 0.56 to 0.98; P = 0.04) (Fig. 8). However, ICU mortality was not different between the high and low PEEP groups among ARDS patients without a positive oxygenation response to PEEP.
Fig. 8

Effect of high PEEP on ICU mortality in ARDS patients

Effect of high PEEP on ICU mortality in ARDS patients For ARDS patients in the low PEEP group who received a PEEP level lower than 10 cmH2O (from 3 RCTs), ICU mortality was lower in the high PEEP group than the low PEEP group (RR = 0.65; 95% CI, 0.45 to 0.94; P = 0.02) (Fig. 9). In contrast, there was no significant difference in ICU mortality between the high and low PEEP groups if the PEEP level was equal and more than 10 cmH2O in the low PEEP group (RR = 0.98; 95% CI, 0.79 to 1.23; P = 0.89) (Fig. 9).
Fig. 9

Effect of high PEEP on ICU mortality while the PEEP level of patients in low PEEP group was different

Effect of high PEEP on ICU mortality while the PEEP level of patients in low PEEP group was different

Effect of high PEEP on clinically objectified barotrauma in ARDS patients

Seven RCTs reported data on clinically objectified barotrauma, including 1746 patients in the high PEEP group and 1768 patients in the low PEEP group. A meta-analysis with a random-effects model showed that the incidence of clinically objectified barotrauma in the high and low PEEP groups were 9.97% (174/1746) and 6.8% (120/1768), respectively. High PEEP did not increase the incidence of clinically objectified barotrauma (RR = 1.24; 95% CI, 0.74 to 2.09, P = 0.41) (Fig. 10). However, in ARDS patients without positive oxygenation response to PEEP, high PEEP increased the incidence of clinically objectified barotrauma (RR = 2.50; 95% CI, 1.64 to 3.79, P < 0.0001) (Fig. 10).
Fig. 10

Effect of high PEEP on clinically objectified barotrauma in ARDS patients

Effect of high PEEP on clinically objectified barotrauma in ARDS patients

Discussion

Our meta-analysis showed that high PEEP did not improve outcomes in patients with ARDS. However, subgroup analysis showed that it may decrease hospital mortality as well as ICU and 28-d mortality in ARDS patients with clinically positive oxygenation response to PEEP. In addition, in ARDS patients without positive oxygenation response to PEEP, high PEEP increased the incidence of clinically objectified barotrauma. The results were different from Goligher’s study [18], which found that recruitment manoeuvres in combination with higher PEEP could reduce mortality in ARDS patients. Evidence from previous studies showed that high PEEP does not decrease mortality in patients with ARDS [7, 8, 19, 20], which is in line with our results. However, several issues must be considered when interpreting this result. First, there was a large variation in the PEEP level between the different studies. For example, Huh et al. [17] set a high PEEP of 10 cmH2O, while the high PEEP was 16.3 cmH2O in Amato’s study [12]. Similarly, the PEEP level varied from 6.5 to 13 cmH2O in the low PEEP groups among the included studies. Therefore, the different PEEP levels may have led to the different results. Subgroup results showed that the PEEP level in the low PEEP group greatly impacted the effect of PEEP on ICU mortality. Second, patient characteristics also impacted the effect of PEEP. Among these studies, the severity of ARDS in patients varied widely. For example, baseline PaO2/FiO2 ranged from 110.8 ± 6.3 to 165 ± 77 mmHg. Oxygenation response to PEEP was also significantly associated with the severity of ARDS. The potential lung with response to PEEP was considerably stronger in more severe ARDS patients than in less severe individuals. A previous meta-analysis showed that a high PEEP reduced mortality in patients with ARDS but not ALI [8] However, in the present study, there was no difference of hospital mortality between groups of ARDS patients with a baseline PaO2/FiO2 less than 150 mmHg. The purpose of PEEP is to recruit collapsed alveoli in a gravity-dependent lung but not to induce the alveoli to overdistend in the non-dependent lung. Patients with ARDS exhibit significant dependent atelectasis due to increased lung weight resulting from interstitial and alveolar edema. Both higher PEEP and recruitment manoeuvres can reduce atelectasis and increase end-expiratory lung volume. Physically, we need higher pressure to open alveoli and only need a relative lower PEEP to keep the lung open. Therefore, it was noted that higher PEEP should follow the recruitment manoeuvres. Goligher et al. showed that combine with recruitment manoeuvres and higher PEEP could reduce mortality of patients with ARDS [18]. The results were also demonstrated in the study by Constantin et al. [21]. However, the study by Goligher et al. [10] indicated that the percentage of potentially respond to PEEP was extremely variable. Our results demonstrated the hypothesis that only patients who respond to increased PEEP by improved oxygenation benefitted more from higher PEEP. PEEP could have different effects on clinical outcomes based on the nature of the clinical response to PEEP itself. In ARDS patients with clinically positive oxygenation response to PEEP, the main effect of a high PEEP might be recruiting the collapsed lung, which may reduce ventilation-induced lung injury (VILI). In contrast, a high PEEP might result in alveolar overdistension, which induces lung injury in ARDS patients without positive oxygenation response to PEEP. These reasons could help to explain why our subgroup analysis showed that high PEEP reduced mortality in ARDS patients with clinically positive oxygenation response to PEEP. The severity of ARDS can be used to titrate PEEP. There are many methods for PEEP titration, such as oxygenation, stress index and transpulmonary pressure. Chiumello et al. found that oxygenation-guided PEEP provided PEEP levels related to oxygenation response to PEEP in the lung that progressively increased from mild to moderate and severe ARDS [19]. In assessing the oxygenation response to PEEP at 5 cmH2O PEEP based on the Berlin definition [6, 22], a simple Friday-night ventilation strategy can be used in patients with ARDS [23]. Therefore, while we only included studies in which the PEEP level was lower than 10 cmH2O in the low PEEP group, decreased ICU mortality was found in the high PEEP group. There are many methods that can be used with ARDS patients at present. To date, prolonged sessions of prone positioning has not only been shown to be efficient at significantly increasing oxygenation and decreasing driving pressure in severe ARDS in the APRONET study [24], but the PROSEVA trial also showed that prone positioning was associated with improved patient survival [25]. However, the LUNG SAFE study showed that the rate of prone positioning was low because of selection bias or the clinician’s perception [26]. On the other hand, neuromuscular blockers could be used in severe ARDS, but they are controversial. Many previous studies found that the mortality of ARDS treated with neuromuscular blockers was not decreased. However, neuromuscular blockers could exert beneficial effects in patients with moderate ARDS, at least in part, by limiting expiratory efforts as shown in Guervilly’s study [27]. In our study, there were 3 RCTs that included prone position or neuromuscular blockers. Unfortunately, due to the lack of prognostic data, statistical analysis was not possible. We did not find a significant difference in clinically objectified barotrauma between high PEEP and low PEEP groups. Lung-protective strategies were used in all of the included studies, which decreased the incidence of clinically objectified barotrauma [28, 29]. In addition, most patients in these studies had moderate or severe ARDS, which indicates that more lung area was responsive to increased PEEP. However, in ARDS patients without positive oxygenation response to PEEP, high PEEP increased the incidence of clinically objectified barotrauma. It was shown in a recent study that an exceedingly high pressure was used to recruit the lung, especially in ARDS patients without positive oxygenation response to PEEP, and mortality may increase [8]. Some limitations of our analysis should be noted. First, we were unable to obtain patient-level data despite asking for these data from the authors of the included studies. The lung oxygenation response to PEEP was evaluated based on the mean PaO2/FiO2 values reported in each study but not the individual patient data. That finding means most of the patients in the study with positive oxygenation response to increased PEEP were in their respective groups. Second, the definition of positive oxygenation response to PEEP based on Goligher’s study is not highly precise [10]. We also did not assess other factors that may affect the oxygenation response to PEEP. These factors may have affected the accuracy of our results. In this meta-analysis, we only included the data from the included studies. In addition, we did not used the data on SpO2, PaCO2 and respiratory compliance at the two different PEEP levels. We only used the PaO2/FiO2 data at higher and lower PEEP levels. Therefore, we defined the groups as positive oxygenation response to PEEP if the mean PaO2/FiO2 was higher in the high PEEP group than at baseline. Based on this definition, we found that patients with clinically positive oxygenation response to PEEP benefitted from high PEEP. Third, the methods of PEEP titration were different between the included studies, which may have induced bias in our study. Oxygenation response to PEEP should be considered during PEEP titration in patients with ARDS. However, no clinical trial has shown that oxygenation response to PEEP using assessment–guided PEEP titration could improve the outcomes in patients with ARDS, which indicates further studies are needed.

Conclusion

In this study, high PEEP did not improve outcomes in patients with ARDS as a whole. However, subgroup analysis showed that high PEEP decreased hospital and ICU mortality in ARDS patients with a clinically objective positive oxygenation response to PEEP. Table S1. Description of Patients, Interventions, Comparators, and Outcomes (PICO) targeted by the systematic review. (DOCX 42 kb) Figure S1. Funnel plot of high PEEP effect on hospital mortality in ARDS patients. (PNG 52 kb) Figure S2. funnel plot of high PEEP effect on hospital mortality while the PEEP level of patients in low PEEP group was different. (PNG 44 kb) Figure S3. Funnel plot of high PEEP effect on hospital mortality of moderate and severe ARDS patients between high and low PEEP groups. (PNG 57 kb) Figure S4. Funnel plot of high PEEP effect on 28-day mortality in ARDS patients. (PNG 53 kb) Figure S5. Funnel plot of high PEEP effect on 28-day mortality while the PEEP level of patients in low PEEP group was different. (PNG 42 kb) Figure S6. Funnel plot of high PEEP effect on ICU mortality in ARDS patients. (PNG 63 kb) Figure S7. Funnel plot of high PEEP effect on ICU mortality while the PEEP level of patients in low PEEP group was different. (PNG 53 kb) Figure S8. Funnel plot of high PEEP effect on clinically objectified barotrauma in ARDS patients. (PNG 46 kb)
  29 in total

Review 1.  Evolution of mechanical ventilation in response to clinical research.

Authors:  Andrés Esteban; Niall D Ferguson; Maureen O Meade; Fernando Frutos-Vivar; Carlos Apezteguia; Laurent Brochard; Konstantinos Raymondos; Nicolas Nin; Javier Hurtado; Vinko Tomicic; Marco González; José Elizalde; Peter Nightingale; Fekri Abroug; Paolo Pelosi; Yaseen Arabi; Rui Moreno; Manuel Jibaja; Gabriel D'Empaire; Fredi Sandi; Dimitros Matamis; Ana María Montañez; Antonio Anzueto
Journal:  Am J Respir Crit Care Med       Date:  2007-10-25       Impact factor: 21.405

2.  Prone positioning in severe acute respiratory distress syndrome.

Authors:  Claude Guérin; Jean Reignier; Jean-Christophe Richard; Pascal Beuret; Arnaud Gacouin; Thierry Boulain; Emmanuelle Mercier; Michel Badet; Alain Mercat; Olivier Baudin; Marc Clavel; Delphine Chatellier; Samir Jaber; Sylvène Rosselli; Jordi Mancebo; Michel Sirodot; Gilles Hilbert; Christian Bengler; Jack Richecoeur; Marc Gainnier; Frédérique Bayle; Gael Bourdin; Véronique Leray; Raphaele Girard; Loredana Baboi; Louis Ayzac
Journal:  N Engl J Med       Date:  2013-05-20       Impact factor: 91.245

3.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Authors:  V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

Review 4.  Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis.

Authors:  Matthias Briel; Maureen Meade; Alain Mercat; Roy G Brower; Daniel Talmor; Stephen D Walter; Arthur S Slutsky; Eleanor Pullenayegum; Qi Zhou; Deborah Cook; Laurent Brochard; Jean-Christophe M Richard; Francois Lamontagne; Neera Bhatnagar; Thomas E Stewart; Gordon Guyatt
Journal:  JAMA       Date:  2010-03-03       Impact factor: 56.272

5.  Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial.

Authors:  Alain Mercat; Jean-Christophe M Richard; Bruno Vielle; Samir Jaber; David Osman; Jean-Luc Diehl; Jean-Yves Lefrant; Gwenaël Prat; Jack Richecoeur; Ania Nieszkowska; Claude Gervais; Jérôme Baudot; Lila Bouadma; Laurent Brochard
Journal:  JAMA       Date:  2008-02-13       Impact factor: 56.272

6.  Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury.

Authors:  Christian Putensen; Nils Theuerkauf; Jörg Zinserling; Hermann Wrigge; Paolo Pelosi
Journal:  Ann Intern Med       Date:  2009-10-20       Impact factor: 25.391

7.  Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials.

Authors:  Ewan C Goligher; Brian P Kavanagh; Gordon D Rubenfeld; Neill K J Adhikari; Ruxandra Pinto; Eddy Fan; Laurent J Brochard; John T Granton; Alain Mercat; Jean-Christophe Marie Richard; Jean-Marie Chretien; Graham L Jones; Deborah J Cook; Thomas E Stewart; Arthur S Slutsky; Maureen O Meade; Niall D Ferguson
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

8.  Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

Authors:  Alexandre Biasi Cavalcanti; Érica Aranha Suzumura; Ligia Nasi Laranjeira; Denise de Moraes Paisani; Lucas Petri Damiani; Helio Penna Guimarães; Edson Renato Romano; Marisa de Moraes Regenga; Luzia Noriko Takahashi Taniguchi; Cassiano Teixeira; Roselaine Pinheiro de Oliveira; Flavia Ribeiro Machado; Fredi Alexander Diaz-Quijano; Meton Soares de Alencar Filho; Israel Silva Maia; Eliana Bernardete Caser; Wilson de Oliveira Filho; Marcos de Carvalho Borges; Priscilla de Aquino Martins; Mirna Matsui; Gustavo Adolfo Ospina-Tascón; Thiago Simões Giancursi; Nelson Dario Giraldo-Ramirez; Silvia Regina Rios Vieira; Maria da Graça Pasquotto de Lima Assef; Mohd Shahnaz Hasan; Wojciech Szczeklik; Fernando Rios; Marcelo Britto Passos Amato; Otávio Berwanger; Carlos Roberto Ribeiro de Carvalho
Journal:  JAMA       Date:  2017-10-10       Impact factor: 56.272

9.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

10.  Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome.

Authors:  Jin Won Huh; Hoon Jung; Hye Sook Choi; Sang-Bum Hong; Chae-Man Lim; Younsuck Koh
Journal:  Crit Care       Date:  2009-02-24       Impact factor: 9.097

View more
  15 in total

1.  Preparing ophthalmologists for the use of mechanical ventilation during the COVID-19 pandemic.

Authors:  Joshua P Harvey; Vita F Sinclair
Journal:  Eye (Lond)       Date:  2020-05-13       Impact factor: 3.775

2.  Efficacy of adaptive ventilation support combined with lung recruitment maneuvering for acute respiratory distress syndrome.

Authors:  Jiandong Zhang; Zhihao Yang; Kun Chen; Xinbo Zhang; Tianhao Zhao; Xiang Zhang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

3.  High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome.

Authors:  Roberto Santa Cruz; Fernando Villarejo; Celica Irrazabal; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

4.  Evidence-Based Practices for Acute Respiratory Failure and Acute Respiratory Distress Syndrome: A Systematic Review of Reviews.

Authors:  Jennifer N Ervin; Victor C Rentes; Emily R Dibble; Michael W Sjoding; Theodore J Iwashyna; Catherine L Hough; Michelle Ng Gong; Anne E Sales
Journal:  Chest       Date:  2020-07-16       Impact factor: 9.410

Review 5.  Acute Respiratory Distress Syndrome.

Authors:  George W Williams; Nathaniel K Berg; Alexander Reskallah; Xiaoyi Yuan; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2021-02-01       Impact factor: 7.892

Review 6.  Obesity as a Risk Factor for Failure to Wean from ECMO: A Systematic Review and Meta-Analysis.

Authors:  Syed Arsalan A Zaidi; Kainat Saleem
Journal:  Can Respir J       Date:  2021-05-22       Impact factor: 2.409

Review 7.  Review 2: Primary graft dysfunction after lung transplant-pathophysiology, clinical considerations and therapeutic targets.

Authors:  Zhaosheng Jin; Ka Chun Suen; Zhiping Wang; Daqing Ma
Journal:  J Anesth       Date:  2020-07-20       Impact factor: 2.078

8.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

9.  Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Crit Care Med       Date:  2020-06       Impact factor: 7.598

Review 10.  Precision Medicine and Heterogeneity of Treatment Effect in Therapies for ARDS.

Authors:  Yasin A Khan; Eddy Fan; Niall D Ferguson
Journal:  Chest       Date:  2021-07-14       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.